Table 3.
Antimicrobial | Total n (%) |
---|---|
Gentamicin | 470 (88.8) |
Cefuroxime | 421 (79.6) |
Benzylpenicillin | 53 (10.0) |
Cefotaxime | 52 (9.8) |
Metronidazole | 17 (3.2) |
Ciprofloxacin | 7 (1.3) |
Ampicillin | 1 (0.2) |
Clindamycin | 1 (0.2) |
Combinations/Treatment regimens | n (%) |
Cefuroxime + gentamicin | 407 (76.9) |
Benzylpenicillin + gentamicin | 53 (10) |
Cefotaxime | 42 (7.9) |
Cefuroxime + gentamicin + metronidazole | 7 (1.3) |
Cefuroxime + metronidazole | 6 (1.1) |
Cefotaxime + ciprofloxacin | 3 (0.6) |
Cefotaxime + gentamicin | 3 (0.6) |
Cefotaxime + metronidazole | 2 (0.4) |
Ciprofloxacin | 2 (0.4) |
Cefuroxime + metronidazole + ciprofloxacin | 1 (0.2) |
Cefotaxime + clindamycin | 1 (0.2) |
Ciprofloxacin + metronidazole | 1 (0.2) |
Ampicillin + cefotaxime | 1 (0.2) |
Denominator for all percentages = 529 neonates who received empirical antimicrobial treatment.